1. Home
  2. NTRA vs AER Comparison

NTRA vs AER Comparison

Compare NTRA & AER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo AerCap Holdings N.V.

AER

AerCap Holdings N.V.

HOLD

Current Price

$139.70

Market Cap

23.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
AER
Founded
2003
1995
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medical Specialities
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
23.1B
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
NTRA
AER
Price
$244.06
$139.70
Analyst Decision
Strong Buy
Buy
Analyst Count
16
6
Target Price
$227.69
$144.17
AVG Volume (30 Days)
1.7M
1.4M
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
0.77%
EPS Growth
N/A
63.90
EPS
N/A
20.89
Revenue
$2,116,676,000.00
$8,344,637,000.00
Revenue This Year
$32.77
$4.58
Revenue Next Year
$16.51
N/A
P/E Ratio
N/A
$6.70
Revenue Growth
38.17
6.67
52 Week Low
$125.38
$85.57
52 Week High
$245.59
$140.73

Technical Indicators

Market Signals
Indicator
NTRA
AER
Relative Strength Index (RSI) 80.03 69.31
Support Level $233.67 $131.62
Resistance Level $240.18 $134.04
Average True Range (ATR) 7.39 2.66
MACD 0.68 0.38
Stochastic Oscillator 97.49 92.05

Price Performance

Historical Comparison
NTRA
AER

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About AER AerCap Holdings N.V.

AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties.It has one business segment: leasing, financing, sales and management of commercial flight equipment (Commercial Flight Equipment Segment).Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include United Kingdom, United States, and Other countries.

Share on Social Networks: